Robert O Messing

24PUBLICATIONS
66CO-AUTHORS
PsychopharmacologyReaction engineering (excl. nuclear reactions)Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Clinical neuropsychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 02, 2026
Identification and validation of central amygdala FGFR1 as a therapeutic target for alcohol use disorder using single-nucleus sequencing in rats.

|Mar 27, 2026
Alternative polyadenylation in the brain is altered by chronic ethanol exposure in a sex- and cell type-specific manner.

Petar N Grozdanov, Laura B Ferguson, Brent R Kisby

|Mar 23, 2026
Alcohol attenuates CRF-induced excitatory effects from the extended amygdala to dorsostriatal cholinergic interneurons.

Amanda Essoh, Xueyi Xie, Himanshu Gangal

|Nov 12, 2024
Next-generation biomarkers for alcohol consumption and alcohol use disorder diagnosis, prognosis, and treatment: A critical review.

Shaunna L Clark, Emily E Hartwell, Doo-Sup Choi

|Mar 21, 2024
Chemogenetic inhibition of central amygdala CRF-expressing neurons decreases alcohol intake but not trauma-related behaviors in a rat model of post-traumatic stress and alcohol use disorder.

Bryan Cruz, Valentina Vozella, Vittoria Borgonetti

|Mar 18, 2024
Brain-specific serine/threonine-protein kinase 1 is a substrate of protein kinase C epsilon involved in sex-specific ethanol and anxiety phenotypes.

Michael P Dugan, Rajani Maiya, Caleb Fleischer

Pageof 4

Frequent Collaborators

4 joint publications

R Adron Harris

2 joint publications

Rajani Maiya

2 joint publications

Marisa Roberto

2 joint publications

R Dayne Mayfield